Activists and 5% owners

Item 4, purpose of the transaction: The information set forth in or incorporated by reference into Item 3 of this Schedule 13D is hereby incorporated by reference in its entirety into this Item 4. The transactions described in Item 3 were undertaken in connection with the Issuer's recapitalization and its acquisition of Beijing Tongsheng Technology Co., Ltd. (the "Acquisition"), pursuant to which the Issuer expects to issue a substantial number of additional Class A Ordinary Shares. In connection with these transactions, the Issuer repurchased from Jolly Harmony 3,769,057 Class A Ordinary Shares and subsequently allotted and issued to Jolly Harmony the same number of Class B Ordinary Shares. The purpose of these transactions …

Item 4, purpose of the transaction: Mr. Singer serves as the President, Chief Executive Officer and Chairman of the Board of the Issuer. In such capacity, Mr. Singer may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. Subject to the Issuer's insider trading policy (the "Insider Trading Policy"), Mr. Singer may from time to time buy or sell securities of the Issuer including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as Mr. Singer may deem advisable as appropriate for the personal circumstances of Mr. Singer. In light of his responsibilities to th…

Item 4, purpose of the transaction: The Reporting Persons acquired the securities reported herein in connection with the transactions contemplated by the Share Acquisition Agreement, dated May 17, 2025, as amended by Amendment No. 1 thereto. Pursuant to Amendment No. 1, the parties, among other things, (i) provided for Ming Kai Trading International Limited's exercise of warrants to acquire an aggregate of 3,050,000 ordinary shares of the Issuer, consisting of 2,000,000 shares underlying maximum eligibility warrants and 1,050,000 shares underlying pre-funded warrants, and (ii) amended the warrants to waive the beneficial ownership limitation and remove the sixty-one (61) day waiting period to permit full exercise. The securit…

Item 4, purpose of the transaction: The Common Stock owned by the Reporting Person was acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.

Item 4, purpose of the transaction: The Common Stock owned by the Reporting Person was acquired for investment purposes. The Reporting Person may make further acquisitions of the Common Stock from time to time. Except for the foregoing, the Reporting Person has no plans or proposals which relate to, or could result in, any of the matters referred to in Item 4 of Schedule 13D.

Item 4, purpose of the transaction: On August 18, 2026, the issuer issued 218,750 shares of common stock to the reporting person in connection with a private placement pursuant to the Private Placement Agreement, dated July 30, 2026. Except as set forth herein, the reporting person does not currently have any plans or proposals that relate to or would result in any of the actions described in Items 4(a) through 4(j) of Schedule 13D. The reporting person, in his capacity as an officer of the issuer, may from time to time engage in discussions with management regarding the issuer's business and operations and may acquire or dispose of securities of the issuer, subject to applicable laws.

Item 4, purpose of the transaction: The information set forth in or incorporated by reference in Item 3 of this Schedule 13D is incorporated by reference in its entirety into this Item 4. The Reporting Persons acquired beneficial ownership of the securities of the Issuer as described in this Schedule 13D for investment and decision-making purposes and intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including but not limited to the Issuer's business, prospects, financial position and strategic direction, price levels of the securities, conditions in the securities markets, and general economic and industry conditions, the Reporting Persons may in the future take such actions…

Item 4, purpose of the transaction: The Reporting Person initially reported its beneficial ownership of greater-than-5% of the shares of Common Stock on Schedule 13G, most recently amended on August 13, 2026. The Reporting Person has been a supportive long term investor in the Issuer and has recently engaged in amicable discussions with the Issuer, including with respect to the possibility of the Issuer extending an offer to Benjamin Hart, an employee of one of the Reporting Person's affiliates, to join the Issuer's board of directors (the "Board"). Accordingly, the Reporting Person is switching to reporting its greater-than-5% beneficial ownership of the shares of Common Stock on Schedule 13D. The Reporting Person acquired…

Item 4, purpose of the transaction: The Reporting Persons acquired the securities reported herein to facilitate the organization and IPO of the Issuer and for investment purposes. The Issuer is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (an "Initial Business Combination"). Mr. McCabe serves as the Chairman and Chief Executive Officer of the Issuer. In such capacities, and through the Sponsor, the Reporting Persons intend to review, evaluate and, where appropriate, participate in discussions or negotiations concerning potential Initial Business Combination candidates…

Item 4, purpose of the transaction: In connection with the organization of the Issuer, on March 20, 2026, pursuant to a Securities Subscription Agreement, the Issuer issued an aggregate of 2,875,000 ordinary shares as Founder Shares to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares included 375,000 ordinary shares that were subject to forfeiture depending on the extent to which the underwriter's over-allotment option was not exercised. On July 27, 2026, the Issuer consummated its initial public offering of 8,625,000 units, including 1,125,000 units issued pursuant to the full exercise of the underwriter's over-allotment option. Accordingly, none of the Founder Shares were forfeited. Simultaneously w…

Item 4, purpose of the transaction: In connection with the organization of the Issuer, on May 29, 2026, pursuant to a Securities Subscription Agreement, the Issuer issued an aggregate of 4,933,500 ordinary shares as Founder Shares to the Sponsor for an aggregate purchase price of $25,000. The Founder Shares include 643,500 ordinary shares that are subject to forfeiture depending on the extent to which the underwriters' over-allotment option is not exercised. On August 10, 2026, the Issuer consummated its initial public offering of 10,000,000 units. As of the date of this Schedule 13D, the underwriters have not exercised the over-allotment option and the period during which they may exercise such option has not expired; accordi…

Item 4, purpose of the transaction: The Reporting Persons acquired the Shares for investment purposes. On August 13, 2026, Mr. Bobulinski, on behalf of GIV, executed a written consent of stockholder in lieu of a meeting consenting to the removal, without cause, of Harit Talwar, Arnaud Massenet, Bhaskar Menon, Prabhu Narasimhan and Daniel Lewis as directors of the Issuer and authorized its delivery to the Issuer. As described in Amendment No. 5 to the Schedule 13D filed by Mr. Garg and certain affiliated persons on August 18, 2026 and their preliminary consent statement filed on August 18, 2026, the delivered consents did not constitute a majority of the Issuer's voting power, and Mr. Garg and the other stockholders whose con…

Item 4, purpose of the transaction: On April 27, 2023, the Issuer issued a Promissory Note to the Sponsor in the original principal amount of up to $2,500,000 (the "Note"), which was subsequently amended and restated on January 8, 2024, and further amended on May 31, 2024 and March 20, 2026. On April 24, 2026, the Issuer and the Sponsor entered into a Note Modification and Conversion Agreement (as amended, the "Conversion Agreement"), which modified the terms of the Note and provided for optional conversion into shares of Common Stock. The Conversion Agreement was amended on April 29, 2026, July 31, 2026, and August 12, 2026. On August 12, 2026, the Sponsor converted $1,292,521 of principal into 1,207,965 shares of Common Stoc…

Item 4, purpose of the transaction: No funds or other consideration were used by the Reporting Person to acquire the shares of Common Stock reported herein. On August 11, the Issuer completed its previously announced merger transaction (the Merger) in accordance with the terms and conditions of the Agreement and Plan of Merger, dated by December 11, 2025, by and among the Issuer, Katapult Merger Sub 1, Inc., Katapult Merger Sub 2, LLC, CCF Holdings LLC, and Aarons Intermediate Holdco, Inc. See Item 2.01 of the Issuers current report on Form 8K filed with the Commission on August 11, 2026 for additional information regarding the completion of the Merger. In connection with the Merger, (a) 22,801,805 shares of Common Stock wer…

Item 4, purpose of the transaction: Any transaction described in this Item 4 is subject to the lock-up agreement described in Item 6, which restricts transfers of Class A Ordinary Shares and securities convertible into or exercisable or exchangeable for Class A Ordinary Shares until February 11, 2027, without the prior written consent of Dominari Securities LLC.

Item 4, purpose of the transaction: Any transaction described in this Item 4 is subject to the lock-up agreement described in Item 6, which restricts transfers of Class A Ordinary Shares and securities convertible into or exercisable or exchangeable for Class A Ordinary Shares until February 11, 2027 without the prior written consent of Dominari Securities LLC.

Item 4, purpose of the transaction: Mr. Akimoto received the 135,454,900 shares of the Issuer's common stock, pursuant to a share exchange agreement between the Issuer and Advasa, Co., Ltd. ("Advasa Japan") and Advasa Japan's shareholders, pursuant to which the Issuer acquired 96.6% ownership interest in Advasa Japan from Advasa Japan's shareholders (one of which was the Reporting Person) in exchange for shares of the Issuer. The Reporting Person from time to time intends to review their investments in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for th…

Item 4, purpose of the transaction: Mr. Kosugi received the 232,638,232 shares of the Issuer's common stock, pursuant to a share exchange agreement between the Issuer and Advasa, Co., Ltd. ("Advasa Japan") and Advasa Japan's shareholders, pursuant to which the Issuer acquired 96.6% ownership interest in Advasa Japan from Advasa Japan's shareholders (one of which was the Reporting Person) in exchange for shares of the Issuer. The Reporting Person from time to time intends to review their investments in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the…

Item 4, purpose of the transaction: The information set forth in Item 3 of this Schedule 13D is incorporated by reference into this Item 4. The Reporting Persons acquired the Shares in order to provide capital for the Issuer's ongoing operating expenses. The Reporting Persons collectively beneficially own an aggregate of 411,522 Shares, which represent 9.4% of the outstanding Shares (based upon the Issuer's outstanding shares of Common Stock as of August 12, 2026). The Subscription Agreement provides that, solely in the event that the Merger Agreement (as defined below) is terminated and the Transactions (as defined below) are not consummated, the Issuer will be required to file a registration statement registering the resale…

Item 4, purpose of the transaction: The information set forth in Item 6 of this Schedule 13D is incorporated herein by reference. The securities reported herein were acquired for investment purposes. The Reporting Person and its affiliates intend to review their investment in the Issuer on an ongoing basis and may seek to increase or decrease their position in the Issuer, including by purchasing additional shares of Class A Common Stock and/or other equity, debt, notes or other financial instruments related to the Issuer. In addition, the Reporting Person and its affiliates may seek to sell or otherwise dispose of some or all securities of the Issuer, including the reported securities and/or other equity, debt, notes or other…

Item 4, purpose of the transaction: The information set forth in Item 3 hereof is hereby incorporated by reference. Lock-Up Agreements In connection and concurrently with the execution and delivery of the Merger Agreement, IQV Holdco and certain other CCF and Aaron's securityholders entered into a lock-up agreement (the "Lock-Up Agreement") with the Issuer, Aaron's and CCFI. The Lock-Up Agreement provides that, among other things, IQV Holdco may not sell, transfer, pledge or dispose of ("Transfer") any Common Stock for six months following the consummation of the Mergers (the "Closing") without the prior written consent from the Issuer, subject to customary exceptions. At six months following the Closing, IQV Holdco (and any…

Item 4, purpose of the transaction: The information set forth in Items 3 and 6 is incorporated by reference in its entirety into this Item 4. On December 11, 2025, the Issuer entered into the Merger Agreement with Merger Sub 1, Merger Sub 2, CCFI, and Aaron's. Pursuant to the Merger Agreement, on August 11, 2026, (i) Merger Sub 1 merged with and into Aaron's, with Aaron's surviving as a wholly owned subsidiary of the Issuer (the "Aaron's Merger"), and (ii) Merger Sub 2 merged with and into CCFI, with CCFI surviving as a wholly owned subsidiary of the Issuer (the "CCFI Merger" and, together with the Aaron's Merger, the "Mergers"). The Mergers were effected as all-stock transactions. No cash consideration was paid. Pursuant to…

Item 4, purpose of the transaction: The information set forth in Items 3, 5 and 6 of this Schedule 13D is incorporated by reference herein. Background On May 14, 2025, the Issuer and 1036030 B.C. Ltd., a company solely owned by the Reporting Person, entered into a consulting services agreement pursuant to which the Reporting Person was granted 2,000,000 Performance Warrants to acquire shares of Common Stock at an exercise price of $0.001 per share, with a term of five years. The Performance Warrants vest contingent upon the occurrence of the following four specified performance milestones: - Milestone 1: 500,000 Performance Warrants shall vest upon the Issuer completing and receiving the results of a three-month collagen stu…

Item 4, purpose of the transaction: This Statement on Schedule 13D relates to the acquisition of Shares by the Reporting Persons. The Shares acquired by the Reporting Persons were acquired for the purpose of making an investment in the Issuer and not with the intention of acquiring control of the Issuer's business on behalf of the Reporting Persons' respective advisory clients. The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other …

Item 4, purpose of the transaction: This Statement on Schedule 13D relates to the acquisition of Shares by the Reporting Persons. The Shares acquired by the Reporting Persons were acquired for the purpose of making an investment in the Issuer and not with the intention of acquiring control of the Issuer's business on behalf of the Reporting Persons' respective advisory clients. The Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other …